Skip to main content
Clinical Trials/NCT05822219
NCT05822219
Active, not recruiting
Not Applicable

Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals With Rheumatic Diseases.

Northwestern University1 site in 1 country60 target enrollmentMarch 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatic Diseases
Sponsor
Northwestern University
Enrollment
60
Locations
1
Primary Endpoint
Receipt of >1 COVID-19 vaccine or booster dose
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.

Detailed Description

Through community-academic partnerships in Boston and Chicago, investigators will recruit and randomly assign POLs who identify as Black with rheumatic conditions to two training arms in each city. Arms 1 and 2 will receive the same core curriculum addressing COVID-19 vaccine hesitancy, safety and efficacy. POLs will work in their communities to distributed information they learned in the trainings to members of their social network. The investigators will gather information about these social networks, assessing for differences in characteristics such as size, location, and who is in it (percentage of family, percentage Black, percentage with rheumatic conditions).

Registry
clinicaltrials.gov
Start Date
March 15, 2024
End Date
March 30, 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rosalind Ramsey-Goldman

Principal Investigator - Chicago

Northwestern University

Eligibility Criteria

Inclusion Criteria

  • 18-85 years old; All genders; English-speaking; Self-identify as Black and/or African descent; Received ≥1 dose of a COVID-19 vaccine after 8.31.2022 (bivalent booster or updated COVID-19 vaccine \[2023-2024\] formula)
  • Social network members:
  • At least 18 years of age; All genders; English-speaking or Haitian Creole or Spanish-speaking if the POL also speaks Haitian Creole or Spanish; Not have received the updated COVID-19 vaccine 2023-2024 formula; Recent (within 3 months) COVID-19 infection and either undecided or no intention of receiving the vaccine.

Exclusion Criteria

  • Both POLs and social network members:
  • Under 18 years of age Pregnant women Institutionalized or incarcerated Those who are up to date on COVID vaccinations

Outcomes

Primary Outcomes

Receipt of >1 COVID-19 vaccine or booster dose

Time Frame: 6 months

This will be measured as documentation of receipt of \>1 additional COVID-19 vaccine or booster dose above network members' baseline number of doses, scored yes or no.

Secondary Outcomes

  • Structure and composition of the Popular Opinion Leader outreach networks.(6 months)
  • Change in COVID-19 vaccine hesitancy(6 months)

Study Sites (1)

Loading locations...

Similar Trials